Mizuho's Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentally
0
0
03/01/24
Dans
Amérique du Nord / États-Unis
Jared Holz, Mizuho healthcare strategist, joins 'Squawk on the Street' to discuss whether the conversation around healthcare will change much relative to last year, whether M&A will be a part of the playbook for Merck and Biogen, and the prospect for weight-loss drugs this year.
Montre plus
0 commentaires
sort Trier par
